ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
andi85
|
1.3K |
558K |
4 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
558K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
andi85
|
362 |
115K |
3 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
362
|
115K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DREAM HF Trial Published in JACC
|
|
andi85
|
111 |
41K |
5 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
111
|
41K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
andi85
|
618 |
241K |
5 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
618
|
241K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
DREAM HF Trial Video
|
|
andi85
|
99 |
34K |
7 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
99
|
34K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
andi85
|
914 |
293K |
2 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
914
|
293K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
andi85
|
576 |
206K |
3 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
576
|
206K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
andi85
|
576 |
206K |
1 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
206K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Capital raising
|
|
andi85
|
197 |
72K |
6 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
197
|
72K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
andi85
|
484 |
148K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
484
|
148K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
Competitive landscape
|
|
andi85
|
3.8K |
1.4M |
1 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
3.8K
|
1.4M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
andi85
|
228 |
126K |
1 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
228
|
126K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
andi85
|
228 |
126K |
1 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
228
|
126K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
andi85
|
228 |
126K |
10 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
228
|
126K
|
10
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip and NVISO Partner on Human Behavioral Analytics in Automotive and Edge AI Devices
|
|
andi85
|
28 |
21K |
1 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
28
|
21K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip and NVISO Partner on Human Behavioral Analytics in Automotive and Edge AI Devices
|
|
andi85
|
28 |
21K |
0 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
28
|
21K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q2 Financial Results and Operational Highlights
|
|
andi85
|
219 |
56K |
13 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
219
|
56K
|
13
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
andi85
|
956 |
298K |
4 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
956
|
298K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
andi85
|
956 |
298K |
2 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
956
|
298K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
Run Hard and Burn the Shorts Regime
|
|
andi85
|
34 |
8.5K |
9 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
34
|
8.5K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip - Continuing concerns about continuous disclosure
|
|
andi85
|
956 |
298K |
9 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
956
|
298K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
andi85
|
151 |
41K |
11 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
151
|
41K
|
11
|
|